This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Knowing when to revisit budget categories helps you rebalance spending before it wrecks your plan.
17,280 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Arizona regulators filed a 20-count complaint alleging Kalshi engaged in illegal gambling and election wagering. The ...
A 98-year look at daily market data reveals tiny weekday patterns in stock returns. Learn which days week yield poten...
FTX will begin a fourth distribution to creditors, totaling $2.2 billion, starting March 31. The move comes as the es...
Insider stock moves can be routine or signaling. This article breaks down the facts behind ford's farley sells 6,454,...
Signet Jewelers stock just moved higher as the company rolls out a growth strategy focused on core brands and smarter...
As March closes, a simple, disciplined core holding stands out for many investors: the Vanguard S&P 500 ETF (VOO). Th...
APM’s Michael Banner says HECM for Purchase has failed to take off due to industry shortcomings rather than product f...
With megacap dominance fading, traders are rethinking how to beat without magnificent risk. Equal-weight strategies a...
Micron stock has surged dramatically, but savvy investors are asking: is it still a bargain? This article breaks down...
As AI reshapes business, three stock ideas stand out for potential multi-year gains. This guide breaks down why, how ...
A CFO sold a sizable block of Perdoceo Education shares during a year of strong stock gains. This guide explains what...